209 related articles for article (PubMed ID: 37544826)
1. Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves' disease: An observational cohort study.
Xu S; Yu H; Cheng X; Wu J; Bao J; Zhang L
Vaccine; 2023 Aug; 41(38):5648-5654. PubMed ID: 37544826
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves' Disease.
Huang L; Jiang Z; Zhou J; Chen Y; Huang H
Front Endocrinol (Lausanne); 2022; 13():835880. PubMed ID: 35651979
[TBL] [Abstract][Full Text] [Related]
3. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
[TBL] [Abstract][Full Text] [Related]
4. Effect of Inactivated and mRNA COVID-19 Vaccination on Thyroid Function Among Patients Treated for Hyperthyroidism.
Wong CH; Leung EKH; Tang LCK; Lee CH; Fong CHY; Lee ACH; Woo YC; Tan KCB; Lui DTW
J Clin Endocrinol Metab; 2023 Apr; 108(5):e76-e88. PubMed ID: 36453154
[TBL] [Abstract][Full Text] [Related]
5. Graves' disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature.
Takedani K; Notsu M; Ishiai N; Asami Y; Uchida K; Kanasaki K
BMC Endocr Disord; 2023 Jun; 23(1):132. PubMed ID: 37316819
[TBL] [Abstract][Full Text] [Related]
6. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
[TBL] [Abstract][Full Text] [Related]
7. The Mediation Role of Thyrotropin Receptor Antibody in the Relationship Between Age and Severity of Hyperthyroidism in Graves' Disease.
Suzuki N; Inoue K; Yoshimura R; Kinoshita A; Suzuki A; Fukushita M; Matsumoto M; Yoshihara A; Watanabe N; Noh JY; Katoh R; Sugino K; Ito K
Thyroid; 2022 Oct; 32(10):1243-1248. PubMed ID: 36074931
[No Abstract] [Full Text] [Related]
8. Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves' disease: a cross-sectional study.
Katahira M; Tsunekawa T; Mizoguchi A; Yamaguchi M; Tsuru K; Takashima H; Terada R
Hormones (Athens); 2023 Jun; 22(2):253-261. PubMed ID: 36811756
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
11. Effect of Selenium Supplementation on Recurrent Hyperthyroidism Caused by Graves' Disease: A Prospective Pilot Study.
Wang L; Wang B; Chen SR; Hou X; Wang XF; Zhao SH; Song JQ; Wang YG
Horm Metab Res; 2016 Sep; 48(9):559-64. PubMed ID: 27392116
[TBL] [Abstract][Full Text] [Related]
12. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
14. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
15. Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: A twelve-month follow-up study.
Morita S; Takagi T; Inaba H; Furukawa Y; Kishimoto S; Uraki S; Shimo N; Takeshima K; Uraki S; Doi K; Imagawa M; Kokawa M; Konami T; Hara H; Hara Y; Sone E; Furuta H; Nishi M; Doi A; Tamura S; Matsuoka TA
Front Endocrinol (Lausanne); 2023; 14():1058007. PubMed ID: 36777341
[TBL] [Abstract][Full Text] [Related]
16. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
17. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
18. GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASE.
Magri F; Zerbini F; Gaiti M; Capelli V; Ragni A; Rotondi M; Chiovato L
Endocr Pract; 2016 Nov; 22(11):1336-1342. PubMed ID: 27540885
[TBL] [Abstract][Full Text] [Related]
19. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK
Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517
[No Abstract] [Full Text] [Related]
20. Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism.
Pyrżak B; Rumińska M; Witkowska-Sędek E; Kucharska A
Front Endocrinol (Lausanne); 2022; 13():877119. PubMed ID: 35600602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]